Recently, United Imaging Healthcare Technology Group Co., Ltd. (hereinafter referred to as the "issuer" or "United Imaging Group") successfully issued the Technology Innovation Corporate Bonds (first tranche) to professional institutional investors in 2024, marking the first issuance of technology innovation corporate bonds for private enterprises in the medical industry nationwide.
The issuance size of this technology innovation corporate bond by United Imaging Group is 1 billion RMB, with a term of 3 years and an issuance interest rate of 3.19%. Both the issuer and the bond rating are AA+, setting a new record for the lowest face interest rate of corporate bonds for private enterprises with the same rating, term, and scale in nearly 8 years, as well as the lowest face interest rate of corporate bonds for private enterprises with the same rating and term in the past 3 years.
United Imaging Group, based on a full line of medical imaging products, empowers each other in medical imaging cloud, medical devices, artificial intelligence, chip development, and third-party precision medical diagnostic services, providing diverse disease solutions and health service models for global users. It aims to build a fully intelligent medical and health ecosystem covering all aspects of prevention, diagnosis, treatment, and rehabilitation.
Llinks fully leveraged its integrated platform advantages, following its assistance to United Imaging Group's subsidiary, United Imaging Medical (Stock Code: 688271), in listing on the Science and Technology Innovation Board, multiple financing, equity incentives, and industrial investments. It further provided legal services for United Imaging Group's technology innovation corporate bond issuance project.
